Utah Committee Advances Bill to Allow Medical Marijuana Telehealth Recommendations, Expand Low-THC Products in Pharmacies

OG article by Anthony Martinelli

February 13, 2026

A Utah House committee advanced House Bill 389, sponsored by Rep. Jennifer Dailey-Provost (D), by an 8-1 vote, expanding access to medical marijuana through telehealth recommendations and allowing certain low-THC products in pharmacies. The bill, amended with minor technical changes, now heads to the full House.

Currently, telehealth certifications for medical marijuana are severely restricted. HB 389 would broaden eligibility, enabling qualified providers to recommend cannabis virtually, benefiting rural residents and those with mobility limitations who face long travel for in-person visits.

The legislation introduces a new “low THC product” category—containing less than 0.3% total THC or analogs, processed by licensed facilities—and permits their sale in medicinal dosage forms through licensed pharmacies under the medical marijuana framework. It also eliminates separate licensing for cannabinoid hemp production by existing cannabis processors.

Additional provisions establish a uniform transaction fee to fund program administration via the Qualified Production Enterprise Fund and restructure the licensing advisory board into a broader Specialized Product Authority Licensing Board overseeing marijuana, hemp, and kratom disputes. Supporters argue the changes improve patient access while maintaining regulatory oversight in Utah’s medical cannabis program.